"10.1371_journal.pmed.1000049","plos medicine","2009-04-21T00:00:00Z","Surender Khurana; Amorsolo L Suguitan; Yonaira Rivera; Cameron P Simmons; Antonio Lanzavecchia; Federica Sallusto; Jody Manischewitz; Lisa R King; Kanta Subbarao; Hana Golding","Division of Viral Products, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration, Bethesda, Maryland, United States of America; Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America; Oxford University Clinical Research Unit, Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam; Institute for Research in Biomedicine, Bellinzona, Switzerland","ICMJE criteria for authorship read and met: SK ALS YR CPS AL FS JM LRK KS HG. Agree with the manuscripts results and conclusions: SK ALS YR CPS AL FS JM LRK KS HG. Designed the experiments/the study: SK CPS KS HG. Analyzed the data: SK ALS YR CPS HG. Collected data/did experiments for the study: SK ALS YR JM LRK. Wrote the first draft of the paper: SK HG. Contributed to the writing of the paper: SK ALS CPS AL KS HG. Conducted virus neutralization assays involving H5N1 wild-type virus and performed preliminary work on evaluating the efficiency of synthetic peptides to block the neutralizing activity of H5 HA-specific hMAbs: ALS. Provided reagents: AL. Supervised the work done at IRB and provided human monoclonal antibodies: FS. Performed the microneutralization assay and analyzed the data from the assays: JM LRK. Designed some of the experiments: KS.","The authors have declared that no competing interests exist.","2009","04","Surender Khurana","SK",10,FALSE,NA,1,5,2,TRUE,TRUE,FALSE,0,NA,FALSE
